
Last updated: 3 months ago
Evogene Ltd. 6-K Report: Shareholder Meeting Approves Key Proposal
Explore Evogene Ltd.'s February 2025 6-K report detailing shareholder approval of a critical proposal, enhancing transparency and governance.
Explore Evogene Ltd.'s February 2025 6-K report detailing shareholder approval of a critical proposal, enhancing transparency and governance.
Xylo Technologies Ltd. reveals L.I.A Pure Capital's request for a shareholder meeting to discuss privatization. Key insights on acquisition, delisting, and legal compliance included.
Explore Alpha Tau Medical Ltd.'s 2024 AGM outcomes, including director elections, auditor re-appointments, and compliance with Israeli law. Key insights for stakeholders.